Originator Organization ETH ZürichStartup |
Active Organization ETH ZürichStartup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC54H50ClF4N11O5S2 |
InChIKeyMKRXFVVTMRJGBY-QYYMYARESA-N |
CAS Registry- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | CH | ETH ZürichStartup | 17 Sep 2019 |